Cure My Disease

Don't miss your cure!

 Log in / Sign up

New acne gel put to the test in everyday life

NCT ID NCT07205107

Ongoing Symptom relief Sponsor: Bausch Health Americas, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows about 200 people aged 12 and older in Canada who are using a prescription gel containing clindamycin, adapalene, and benzoyl peroxide for acne. Researchers want to see how satisfied patients are, how well they stick to the treatment, and how it affects their quality of life over 20 weeks. The goal is to understand how this triple-combination treatment works in real-world settings, not just in controlled trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
clindamycin phosphate, adapalene, and benzoyl peroxide gel
What this could lead to
If successful, this study could show that this triple-combination gel is a well-liked and effective option for managing acne in everyday use.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by factors like how people use other skin products. It also only follows people for 20 weeks, so long-term effects aren't measured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE VULGARIS

Contacts and locations

Locations

  • CHARM Site 001

    Edmonton, Alberta, T6W 0J5, Canada

  • CHARM Site 002

    Toronto, Ontario, M5A 3R6, Canada

  • CHARM Site 003

    Winnipeg, Manitoba, R3M 3Z4, Canada

  • CHARM Site 005

    Toronto, Ontario, M4E 1R7, Canada

  • CHARM Site 006

    Pointe-Claire, Quebec, H9R 5M7, Canada

  • CHARM Site 007

    Calgary, Alberta, T2J 7E1, Canada

  • CHARM Site 008

    Montreal, Quebec, H1Y 3L1, Canada

  • CHARM Site 010

    Markham, Ontario, L3P 1X3, Canada

  • CHARM Site 011

    Richmond Hill, Ontario, L4B 1L1, Canada

  • CHARM Site 012

    Vancouver, British Columbia, V5Z 1H2, Canada

  • CHARM Site 013

    Newmarket, Ontario, L3Y 5G8, Canada

  • CHARM Site 014

    Toronto, Ontario, M4W 2N2, Canada

  • CHARM Site 015

    Ottawa, Ontario, K1V 7Z5, Canada

  • CHARM Site 016

    Toronto, Ontario, M2N 3A6, Canada

  • CHARM Site 017

    Surrey, British Columbia, V3V 0C6, Canada

  • CHARM Site 018

    Québec, Quebec, G1W 4R4, Canada

  • CHARM Site 019

    Windsor, Ontario, N8W 5L7, Canada

  • CHARM Site 021

    Hamilton, Ontario, L8P 4B4, Canada

  • CHARM Site 022

    North York, Ontario, M3B 0A7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.